Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer [Phase 3]
Phase 3 trial of PROSTVAC-V/F with or without GM-CSF in men with asymptomatic or minimally symptomatic metastatic castration-resistant prost…
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy [NA]
A completed clinical trial evaluating the safety and efficacy of the BioProtect Balloon in prostate cancer patients receiving radiotherapy; …
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy [Phase 2]
Phase 2 clinical trial of a combination including ketoconazole, hydrocortisone, and GM-CSF in progressive prostate cancer after hormone ther…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
A pilot study evaluating hormonal therapy in combination with central memory T cells for advanced prostate cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 trial assessing TAK-700 in combination with docetaxel and prednisone for metastatic castration-resistant prostate cancer has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Study of Focal Cryoablation in Low-Risk Prostate Cancer [Phase 2]
Phase 2 clinical trial investigating focal cryoablation for low-risk prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating postoperative radiation therapy with hormonal therapy and concurrent docetaxel for high-risk prostate cancer; stu…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating single dose radiotherapy with or without adjuvant systemic therapy for oligometastatic prostate can…
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer [Phase 1, Phase 2]
Clinical trial evaluation of SM88 in prostate cancer has completed Phase 1 and Phase 2, assessing efficacy, safety, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™ [Phase 2]
Phase 2 open-extension study evaluating YONSA in metastatic prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy [Phase 3]
Phase 3 trial evaluating abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer after failure of docetaxel-b…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer [Phase 2]
Phase 2 clinical trial update for Ga-68 PSMA ligand used to localize prostate cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. [Phase 3]
Phase 3 clinical trial comparing TOOKAD Soluble to active surveillance for localized prostate cancer has completed evaluating efficacy and s…
-
FDA approval · 2019-07-10FDA Approved: ABIRATERONE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' original application for ABIRATERONE acetate as a generic version for prostate cancer (metastatic castr…
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases [Phase 2]
Phase 2 trial evaluating androgen deprivation therapy with or without Radium-223 dichloride in metastatic prostate cancer with bone metastas…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating prevention of micro-architectural bone decay in men with non-metastatic prostate cancer on androgen d…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating androgen deprivation therapy combined with external beam radiotherapy and stereotactic radiosurgery boos…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating the effect of food on the pharmacokinetics of abiraterone acetate in patients with castration-resistant pr…
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Genistein in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 trial of Genistein in prostate cancer patients has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 trial evaluating capecitabine in metastatic prostate cancer unresponsive to hormone therapy has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Vinorelbine in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating vinorelbine in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients [NA]
Phase II investigation on prostate artery embolization before radical prostatectomy in prostate cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide [Phase 2]
Phase 2 trial comparing cabazitaxel versus switch to alternative AR-targeted therapy (enzalutamide or abiraterone) in metastatic castration-…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating cixutumumab plus temsirolimus in metastatic prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A registry study update on sipuleucel-T therapy in men with advanced prostate cancer, with completed status and results posted in 2019.